Call for Papers
Submission Period
Tuesday, October 18, 2022 - | Thursday, December 1 (JST) Monday, December 12 (JST) Monday, December 19 (JST) Abstract Submission has been closed. |
---|
Guidelines for Submission
Type of Presentations
- Oral
- Poster
- Oral and Poster
* The acceptance / rejection and presentation format will be decided by the program committee.
Qualification for Applicants
- The speaker should pay registration fee for JSTH.
- The first speaker is limited to academic members. If you are not enrolled, please complete the enrollment procedure from the following before registering your abstract.
The Japanese Society on Thrombosis and Hemostasis
http://www.jsth.org/registration/
* Only available in Japanese: You may ask for the person who can understand Japanese.
Abstract Category
The submitter is required to select the most appropriate category from the following list for the abstract in the submission.
Main classification
- Coagulation and bleeding disorders
- Thrombotic disorders
- fibrinolysis
- platelet/VWF
- Vasculature/Immunology/Others
Sub classification
- basic research
- pathological analysis
- diagnosis/methods
- treatment/prevention
- others
Instruction for Abstracts Submission
- Registration is only from E-mail:endai-45jsth[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )
- If you do not receive the confirmation e-mail within one day after submitting the abstract, which could be the possibility of submitted improperly, please contact the Secretariat by e-mail (endai-45jsth[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )). Secretariat is not responsible for the incident when you leave the case without receiving the confirmation e-mail.
- Secretariat is not responsible for the corrections of the information submitted by applicants. Please confirm your application before submitting. Furthermore, secretariat is not responsible when applicants have imperfect submission due to their Internet environment or technical problems.
Abstract Format
Abstract Title - Abstract title should be max. 90 characters.
The total length of the abstract should be max. 1470 characters
Acceptance/Rejection
The Program committee has the final decisions of acceptance/rejection of the applied papers and presentation preference.
Inquiries
Congress Secretariat of The 45th Congress of the Japanese Society on Thrombosis and Hemostasis
c/o Japan Convention Services, Inc.
E-mail:endai-45jsth[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )